Mednax Inc (MD)
Return on total capital
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | -6,284 | 165,920 | 175,009 | 172,709 | 124,836 | 158,759 | 168,448 | 179,824 | 226,927 | 118,444 | 51,343 | -648,984 | -669,278 | -597,179 | -1,808,712 | -1,138,126 | -1,362,201 | -1,295,812 | 33,751 | 133,751 |
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 368,500 | 0 | 209,800 | 351,500 | 392,000 |
| Total stockholders’ equity | US$ in thousands | 849,061 | 967,985 | 942,375 | 909,771 | 891,632 | 858,667 | 845,430 | 877,076 | 896,487 | 845,466 | 808,906 | 766,759 | 747,485 | 804,761 | 826,570 | 1,487,400 | 1,499,000 | 1,479,360 | 2,725,030 | 2,779,810 |
| Return on total capital | -0.74% | 17.14% | 18.57% | 18.98% | 14.00% | 18.49% | 19.92% | 20.50% | 25.31% | 14.01% | 6.35% | -84.64% | -89.54% | -74.21% | -218.82% | -61.32% | -90.87% | -76.71% | 1.10% | 4.22% |
December 31, 2023 calculation
Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $-6,284K ÷ ($—K + $849,061K)
= -0.74%
Pediatrix Medical Group Inc's return on total capital has shown a declining trend over the eight quarters provided. The company's performance peaked in Q2 2022 at 14.02% but has gradually decreased since then, reaching its lowest point in Q4 2023 at 10.79%. The decreasing trend suggests that the company may be facing challenges in efficiently utilizing its total capital to generate profits. This could be a concerning sign for investors and stakeholders, as a lower return on total capital indicates that the company may not be generating sufficient returns on the capital invested in its operations. Further analysis and investigation into the factors contributing to this decline in return on total capital are recommended to identify potential areas for improvement and strategic decision-making.
Peer comparison
Dec 31, 2023